These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

270 related items for PubMed ID: 17659701

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Anti-RhoA and anti-RhoC siRNAs inhibit the proliferation and invasiveness of MDA-MB-231 breast cancer cells in vitro and in vivo.
    Pillé JY, Denoyelle C, Varet J, Bertrand JR, Soria J, Opolon P, Lu H, Pritchard LL, Vannier JP, Malvy C, Soria C, Li H.
    Mol Ther; 2005 Feb; 11(2):267-74. PubMed ID: 15668138
    [Abstract] [Full Text] [Related]

  • 5. siRNA Targeting of the SNCG Gene Inhibits the Growth of Gastric Carcinoma SGC7901 Cells in vitro and in vivo by Downregulating the Phosphorylation of AKT/ERK.
    Fan C, Liu J, Tian J, Zhang Y, Yan M, Zhu C.
    Cytogenet Genome Res; 2018 Feb; 154(4):209-216. PubMed ID: 29902801
    [Abstract] [Full Text] [Related]

  • 6. Silencing of RhoA and RhoC expression by RNA interference suppresses human colorectal carcinoma growth in vivo.
    Wang H, Zhao G, Liu X, Sui A, Yang K, Yao R, Wang Z, Shi Q.
    J Exp Clin Cancer Res; 2010 Sep 09; 29(1):123. PubMed ID: 20828398
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. RhoA and RhoC proteins promote both cell proliferation and cell invasion of human oesophageal squamous cell carcinoma cell lines in vitro and in vivo.
    Faried A, Faried LS, Kimura H, Nakajima M, Sohda M, Miyazaki T, Kato H, Usman N, Kuwano H.
    Eur J Cancer; 2006 Jul 09; 42(10):1455-65. PubMed ID: 16750623
    [Abstract] [Full Text] [Related]

  • 9. Up-regulation of small GTPases, RhoA and RhoC, is associated with tumor progression in ovarian carcinoma.
    Horiuchi A, Imai T, Wang C, Ohira S, Feng Y, Nikaido T, Konishi I.
    Lab Invest; 2003 Jun 09; 83(6):861-70. PubMed ID: 12808121
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. "Smart" Nanoparticles Enhance the Cytoplasmic Delivery of Anti-RhoC Silencing RNA and Inhibit the Migration and Invasion of Aggressive Breast Cancer Cells.
    Kaushal N, Durmaz YY, Bao L, Merajver SD, ElSayed ME.
    Mol Pharm; 2015 Jul 06; 12(7):2406-17. PubMed ID: 26020100
    [Abstract] [Full Text] [Related]

  • 14. Specific induction of migration and invasion of pancreatic carcinoma cells by RhoC, which differs from RhoA in its localisation and activity.
    Dietrich KA, Schwarz R, Liska M, Grass S, Menke A, Meister M, Kierschke G, Längle C, Genze F, Giehl K.
    Biol Chem; 2009 Oct 06; 390(10):1063-77. PubMed ID: 19642867
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Clinical and prognostic significance of RhoA and RhoC gene expression in esophageal squamous cell carcinoma.
    Faried A, Faried LS, Usman N, Kato H, Kuwano H.
    Ann Surg Oncol; 2007 Dec 06; 14(12):3593-601. PubMed ID: 17896152
    [Abstract] [Full Text] [Related]

  • 17. [Correlation of expression of RhoA (RhoC and their effector ROCK-1 with malignant phenotype of ovarian cancer cells in vitro].
    Han ZQ, Zhang AL, Wu MF, Liu YL, Chen G, Li FJ, Gao QL, Liao GN, Lu YP, Wang SX, Ma D.
    Zhonghua Zhong Liu Za Zhi; 2004 Jul 06; 26(7):385-8. PubMed ID: 15355639
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.